ATE529413T1 - Verfahren zur synthese von aryloxydiaminopyrimidinen - Google Patents

Verfahren zur synthese von aryloxydiaminopyrimidinen

Info

Publication number
ATE529413T1
ATE529413T1 AT06778311T AT06778311T ATE529413T1 AT E529413 T1 ATE529413 T1 AT E529413T1 AT 06778311 T AT06778311 T AT 06778311T AT 06778311 T AT06778311 T AT 06778311T AT E529413 T1 ATE529413 T1 AT E529413T1
Authority
AT
Austria
Prior art keywords
aryloxydiaminopyrimidines
synthesis
compound
formula
treating
Prior art date
Application number
AT06778311T
Other languages
English (en)
Inventor
Anton Constantinescue
Keena Lynn Green
Gary R Lee
Patrick Finbar Mcgarry
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE529413T1 publication Critical patent/ATE529413T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06778311T 2005-09-01 2006-08-21 Verfahren zur synthese von aryloxydiaminopyrimidinen ATE529413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71328005P 2005-09-01 2005-09-01
PCT/EP2006/065523 WO2007025898A1 (en) 2005-09-01 2006-08-21 Process for synthesis of aryloxy diaminopyrimidines

Publications (1)

Publication Number Publication Date
ATE529413T1 true ATE529413T1 (de) 2011-11-15

Family

ID=37086108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778311T ATE529413T1 (de) 2005-09-01 2006-08-21 Verfahren zur synthese von aryloxydiaminopyrimidinen

Country Status (9)

Country Link
US (1) US7741484B2 (de)
EP (1) EP1926716B1 (de)
JP (1) JP4820873B2 (de)
CN (1) CN101253158B (de)
AT (1) ATE529413T1 (de)
CA (1) CA2620033C (de)
ES (1) ES2374750T3 (de)
TW (1) TW200738650A (de)
WO (1) WO2007025898A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2619898C (en) * 2005-09-01 2014-03-18 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
EP2079713B1 (de) * 2006-10-04 2014-04-16 F. Hoffmann-La Roche AG Verfahren zur synthese von phenoxy-diaminopyrimidin-derivaten
CN102351655A (zh) * 2011-08-18 2012-02-15 杭州澳赛诺化工有限公司 一种4-异丙基间苯二酚的合成方法
JP6546592B2 (ja) 2013-08-23 2019-07-17 アファレント ファーマシューティカルズ インコーポレイテッド 急性、亜急性または慢性の咳を治療するためのジアミノピリミジンp2x3およびp2x2/3受容体モジュレーター
WO2016004358A1 (en) 2014-07-03 2016-01-07 Afferent Pharmaceuticals, Inc. Methods and compositions for treating diseases and conditions
HUE061764T2 (hu) 2015-09-29 2023-08-28 Afferent Pharmaceuticals Inc Diaminopirimidin-P2X3 és P2X2/3 receptor modulátorok felhasználásra köhögés kezelésében
CA3096505A1 (en) * 2018-04-23 2019-10-31 Merck Sharp & Dohme Corp. Novel process for synthesis of a phenoxy diaminopyrimidine compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285728B6 (sk) 1999-04-15 2007-07-06 Basf Aktiengesellschaft Spôsob prípravy substituovaných pyrimidínov
DK1725540T5 (da) * 2004-03-05 2012-10-22 Hoffmann La Roche Diaminopyrimidiner som p2x3- og p2x2/3-antagonister
CA2619898C (en) * 2005-09-01 2014-03-18 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators

Also Published As

Publication number Publication date
EP1926716A1 (de) 2008-06-04
CA2620033A1 (en) 2007-03-08
TW200738650A (en) 2007-10-16
JP4820873B2 (ja) 2011-11-24
CN101253158A (zh) 2008-08-27
JP2009506997A (ja) 2009-02-19
US20070049751A1 (en) 2007-03-01
ES2374750T3 (es) 2012-02-21
US7741484B2 (en) 2010-06-22
EP1926716B1 (de) 2011-10-19
WO2007025898A1 (en) 2007-03-08
CN101253158B (zh) 2013-07-10
CA2620033C (en) 2014-12-02

Similar Documents

Publication Publication Date Title
CY1107846T1 (el) Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες
EA201100094A1 (ru) Тиадиазолилоксифениламидины и их применение в качестве фунгицидов
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
RU2012103850A (ru) Би-арил-мета-пиримидиновые ингибиторы киназ
EA200702413A1 (ru) Способ получения 1-алкил-3-фенилурацилов
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
EA200970605A1 (ru) Ингибиторы mapk/erk-киназ
EA201170168A1 (ru) Комплекс (минерал-аминокислота)-полисахарид
EA201100093A1 (ru) Тиадиазолилоксифениламидины и применение их в качестве фунгицидов
EA201170154A1 (ru) Производные пиридинопиридинонов, способ их получения и применение в терапии
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
EA200701707A1 (ru) Пиразолопиримидины
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
DE602006017918D1 (de) Verfahren zur Herstellung von Telmisartan
ATE525364T1 (de) Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten
ATE529413T1 (de) Verfahren zur synthese von aryloxydiaminopyrimidinen
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE496914T1 (de) Verfahren zur synthese von triazolen
TW200612959A (en) Method for preparing hydroxamic acids
EA200701852A1 (ru) Производные аминокислот
ATE526312T1 (de) Verfahren zur herstellung von reinen 4- pyrrolidinophenylbenzyletherderivaten als maob- inhibitoren
ATE423775T1 (de) Verfahren zur herstellung von lactonen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties